1. Home
  2. RIGL vs BBSI Comparison

RIGL vs BBSI Comparison

Compare RIGL & BBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rigel Pharmaceuticals Inc.

RIGL

Rigel Pharmaceuticals Inc.

N/A

Current Price

$39.76

Market Cap

911.8M

Sector

Health Care

ML Signal

N/A

Logo Barrett Business Services Inc.

BBSI

Barrett Business Services Inc.

N/A

Current Price

$30.76

Market Cap

752.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
RIGL
BBSI
Founded
1996
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
911.8M
752.2M
IPO Year
2000
1994

Fundamental Metrics

Financial Performance
Metric
RIGL
BBSI
Price
$39.76
$30.76
Analyst Decision
Buy
Buy
Analyst Count
4
3
Target Price
★ $64.40
$39.75
AVG Volume (30 Days)
★ 204.0K
138.6K
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
★ 1.06%
EPS Growth
★ 1867.68
5.05
EPS
★ 1.97
0.60
Revenue
$294,282,000.00
★ $920,432,000.00
Revenue This Year
$5.32
$3.97
Revenue Next Year
$24.14
$5.34
P/E Ratio
★ $21.00
$50.13
Revenue Growth
★ 64.15
9.50
52 Week Low
$24.84
$25.33
52 Week High
$52.61
$42.25

Technical Indicators

Market Signals
Indicator
RIGL
BBSI
Relative Strength Index (RSI) 34.58 41.87
Support Level $37.60 $29.41
Resistance Level $43.74 $32.65
Average True Range (ATR) 2.72 1.50
MACD -0.62 -0.10
Stochastic Oscillator 15.98 21.32

Price Performance

Historical Comparison
RIGL
BBSI

About RIGL Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, REZLIDHIA (olutasidenib), GAVRETO (pralsetinib), R289, and Ocadusertib (Systemic) - Eli Lilly.

About BBSI Barrett Business Services Inc.

Barrett Business Services Inc is a provider of business management solutions for small and mid-sized companies through a platform that combines management consulting expertise with human resource tools to help business owners manage and operate their businesses more effectively. The company has two categories of services: Professional Employer Services (PEO) and Staffing. The majority of revenue is derived from the Professional Employer Services segment, which provides clients with human resource advisory services, HRIS access, retirement plans, a learning management system, and a web-based technology platform, myBBSI.

Share on Social Networks: